Bristol-Myers Squibb Company (BMY) vs Chubb Limited (CB)
CB leads on 8 of 14 compared metrics.
A side-by-side comparison of Bristol-Myers Squibb Company and Chubb Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BMY
Bristol-Myers Squibb Company
$57.13Healthcare
CB
Chubb Limited
$328.14Financial Services
Total return — BMY vs CB
growth of $100 · last 30yBMY +168.8%CB +2093.4%CB compounded faster
Log scale — wide-divergence pair
BMY CB
BMY vs CB: by the numbers
- •CB is the larger company ($127.27B vs $116.66B market cap).
- •CB trades at the lower earnings multiple (11.59 vs 16.05 P/E).
- •CB converts more revenue to profit (18.48% vs 15.01% net margin).
- •CB grew revenue faster over the past five years (9.76% vs 2.52% CAGR).
- •BMY pays the higher dividend yield (4.38% vs 1.20%).
Which is better, BMY or CB?
Metric tally: BMY 6 · CB 8It depends on what you're optimizing for:
ValueCB(lower P/E)
GrowthCB(faster 5Y revenue CAGR)
IncomeBMY(higher dividend yield)
QualityBMY(higher ROIC)
Metrics side by side
Valuation
| Metric | BMY | CB |
|---|---|---|
| P/E ratio | 16.05 | 11.59● |
| Forward P/E | 9.31● | 12.11 |
| P/S ratio | 2.41 | 2.12● |
| P/B ratio | 5.82 | 1.75● |
| PEG ratio | 1.71 | 0.93● |
| EV / EBITDA | 11.03 | — |
| FCF yield | 10.20% | — |
Profitability
| Metric | BMY | CB |
|---|---|---|
| Gross margin | 68.75%● | 35.20% |
| Operating margin | 25.67%● | 18.61% |
| Net margin | 15.01% | 18.48%● |
| ROE | 36.25%● | 15.31% |
| ROIC | 13.90%● | 7.95% |
Dividends
| Metric | BMY | CB |
|---|---|---|
| Dividend yield | 4.38%● | 1.20% |
| Payout ratio | 72.25% | 15.17% |
Growth (annualized)
| Metric | BMY | CB |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 9.76%● |
| EPS CAGR (5Y) | 9.38% | 27.08%● |
| FCF CAGR (5Y) | -2.50% | — |
| Total return CAGR (5Y) | 0.74% | 16.27%● |
Frequently asked
- Which is better, BMY or CB?
- It depends on your goal. value: CB (lower P/E); growth: CB (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, CB leads 8 to 6.
- Is BMY or CB cheaper?
- On trailing earnings, CB is cheaper: BMY trades at a 16.05 P/E and CB at 11.59.
- Which has grown faster, BMY or CB?
- Over the past five years, CB grew revenue faster — BMY at a 2.52% CAGR versus CB at 9.76%.
- Does BMY or CB pay a bigger dividend?
- BMY yields 4.38% and CB yields 1.20% based on trailing dividends and the latest price.
- Is BMY or CB more profitable?
- CB runs the higher net margin — BMY at 15.01% versus CB at 18.48%.
- Which has been the better investment, BMY or CB?
- Over the past 10-year, CB delivered the higher annualized total return — BMY at 1.08% versus CB at 12.13%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioChubb P/E ratioBristol-Myers Squibb dividend yieldChubb dividend yieldBristol-Myers Squibb ROEChubb ROEBristol-Myers Squibb operating marginChubb operating marginBristol-Myers Squibb revenue growthChubb revenue growthBristol-Myers Squibb free cash flowChubb free cash flow
Bristol-Myers Squibb & Chubb appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.